[1]
Syed Ahsan Ali Shah, “BISPECIFIC ANTIBODIES IN RELAPSED REFRACTORY MULTIPLE MYELOMA: A SYSTEMATIC REVIEW OF EFFICACY AND SAFETY IN PHASE I/II/III CLINICAL TRIAL”, J Popl Ther Clin Pharmacol, vol. 31, no. 3, pp. 622–629, Mar. 2024, doi: 10.53555/jptcp.v31i3.4993.